Healius Overview
- Year Founded
-
1985
- Status
-
Public
- Employees
-
11,000
- Stock Symbol
-
HLS
- Investments
-
9
- Share Price
-
$0.41
- (As of Thursday Closing)
Healius General Information
Description
Healius is one of Australia's pathology providers, operating a national network of laboratories and collection centres. Pathology generates nearly all group revenue, the majority of which comes from bulk-billed tests funded through the government's Medicare Benefits Schedule, with the remainder from public hospital contracts, private health funds, and specialty services, including genomics and veterinary pathology.
Contact Information
Website
www.healius.com.auCorporate Office
- Level 22
- 161 Castlereagh Street
- Sydney, New South Wales 2000
- Australia
Corporate Office
- Level 22
- 161 Castlereagh Street
- Sydney, New South Wales 2000
- Australia
Healius Stock Performance
As of 19-Nov-2026, Healius’s stock price is $0.41. Its current market cap is $296M with 726M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.41 | $0.39 | $0.21 - $0.70 | $296M | 726M | 5.1M | -$0.39 |
Healius Financials Summary
As of 30-Jun-2026, Healius has a trailing 12-month revenue of $930M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 806,351 | 806,351 | 1,210,630 | 1,741,616 |
| Revenue | 930,245 | 930,245 | 869,723 | 1,144,351 |
| EBITDA | (68,082) | (68,082) | (195,853) | (195,356) |
| Net Income | (281,539) | (281,539) | (97,829) | (423,217) |
| Total Assets | 975,576 | 975,576 | 1,160,717 | 1,993,704 |
| Total Debt | 685,711 | 685,711 | 595,578 | 1,068,036 |
Healius Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Healius Comparisons
Industry
Financing
Details
Healius Competitors (1)
One of Healius’s competitors is BioReference Health, a Corporate Backed or Acquired company based in Elmwood Park, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioReference Health | Corporate Backed or Acquired | Elmwood Park, NJ |
Healius Signals
Healius Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Healius Investments & Acquisitions (9)
Healius’s most recent deal was a Merger/Acquisition with Agilex Biolabs for . The deal was made on 31-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Agilex Biolabs | 31-Jan-2022 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Axis Diagnostic Holdings | 01-Jul-2021 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Montserrat Day Hospitals | 21-Sep-2018 | Merger/Acquisition | Hospitals/Inpatient Services | ||
| Brisbane Private Imaging | 01-Jan-2018 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Healthscope (Queensland Operations) | 16-Jun-2016 | Merger/Acquisition | Clinics/Outpatient Services |
Healius ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
19.09 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Services
Subindustry
of 97
Rank
Percentile
Healius Exits (4)
Healius’s most recent exit was on 21-Sep-2018 from Montserrat Day Hospitals. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Montserrat Day Hospitals | 21-Sep-2018 | Completed |
|
||
| Transport Health | 01-Nov-2014 | Completed |
|
||
| Faulding | 08-Nov-2007 | Completed |
|
||
| Faulding | PIPE | Completed |
Healius Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Agilex Biolabs | Thebarton, Australia | 1996 |
Healius FAQs
-
When was Healius founded?
Healius was founded in 1985.
-
Where is Healius headquartered?
Healius is headquartered in Sydney, Australia.
-
What is the size of Healius?
Healius has 11,000 total employees.
-
What industry is Healius in?
Healius’s primary industry is Laboratory Services (Healthcare).
-
Is Healius a private or public company?
Healius is a Public company.
-
What is Healius’s stock symbol?
The ticker symbol for Healius is HLS.
-
What is the current stock price of Healius?
As of 19-Nov-2026 the stock price of Healius is $0.41.
-
What is the current market cap of Healius?
The current market capitalization of Healius is $296M.
-
What is Healius’s current revenue?
The trailing twelve month revenue for Healius is $930M.
-
Who are Healius’s competitors?
BioReference Health is a competitor of Healius.
-
What is Healius’s annual earnings per share (EPS)?
Healius’s EPS for 12 months was -$0.39.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process